Meet Our Team
A team that’s raised $60M+, built five products into five exits and IPOs worth $3B+ — powered by deep scientific rigor, AAV gene-delivery expertise, and the veterinarian behind our first-in-dog pilot.
Oded Biran
LL.B. — CEO & Chair
Led the Rosetta Genomics turnaround, raising over $60M and bringing five products to market.
Efrat Eliyahu
PhD — CSO
Inventor of the Khepri technology. Sphingolipid biology and IP development.
Sergei Petukhov
DVM — CBO
Physician-scientist in gene therapy; builds large-animal disease models.
Natasha Shtraizent
PhD — COO
Biochemistry and sphingolipid metabolism. Runs operations and regulatory.
Phillip Putter
DVM — CMO
Head of SpotOn Veterinary Hospital; principal investigator for the canine studies.
Dr. Stephen Chang
PhD — CTO
Decades in AAV vector development. Former CSO, New York Stem Cell Foundation.
Get in Touch
Pet parent, veterinarian, or investor — we’d love to hear from you.
General Inquiries
Veterinarians & Trial Sites
Investors
[Placeholder emails — replace with Khepri’s actual addresses.]
Follow Khepri
[Placeholder handles/URLs — replace with Khepri’s real social profiles once created.]
Khepri 